According to recent observations in TTP/HUS registries, emerging features of these disorders are the diagnostic value of ADAMTS13 measurement, efficacy of plasma exchange (PEX), and frequency of relapses after remission [17,18]. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.